Apogee Therapeutics Inc (APGE)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | APGE | CRSP | NNNN | ||
| Company | Apogee Therapeutics Inc | Crispr Therapeutics Ag | Anbio Biotechnology Cl A | ||
| Price Information | |||||
| Exchange | NASDAQ | NASDAQ | NASDAQ | ||
| Open | 77.78 | 56.45 | 32.17 | ||
| High | 78.74 | 56.83 | 37.02 | ||
| Low | 76.76 | 55.21 | 32.17 | ||
| Latest | 78.09 | 56.71 | 35.84 | ||
| Change | +0.79 | +0.25 | +1.23 | ||
| % Change | +1.02% | +0.44% | +3.55% | ||
| Volume | 465,100 | 652,900 | 47,200 | ||
| 20-Day Average Volume | 946,410 | 1,715,965 | 34,375 | ||
| Previous Close | 77.30 | 56.46 | 34.61 | ||
| Industry | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | ||
| Has Options | Yes | Yes | No | ||
| Technicals | |||||
| 20-Day Moving Average | 75.21 | 55.85 | 31.48 | ||
| 20-Day Raw Stochastic | 78.21% | 65.11% | 63.26% | ||
| 20-Day Relative Strength | 69.01 | 49.78 | 57.65 | ||
| Weighted Alpha | +92.22 | +33.92 | +20.69 | ||
| Today's Opinion | 100% Buy | 8% Buy | 56% Buy | ||
| Previous Opinion | 100% Buy | 8% Buy | 56% Buy | ||
| Last Month's Opinion | 100% Buy | 8% Sell | 56% Sell | ||
| Performance | |||||
| 5-Days | |||||
| %Chg | +3.43% since 12/17/25 | +3.60% since 12/17/25 | +13.78% since 12/17/25 | ||
| Low | 74.54 on 12/18/25 | 54.50 on 12/22/25 | 28.38 on 12/18/25 | ||
| High | 80.99 on 12/19/25 | 59.18 on 12/22/25 | 37.02 on 12/24/25 | ||
| 1-Month | |||||
| %Chg | +15.09% since 11/24/25 | +10.65% since 11/24/25 | +48.41% since 11/24/25 | ||
| Low | 67.66 on 11/25/25 | 49.96 on 11/25/25 | 20.53 on 11/26/25 | ||
| High | 80.99 on 12/19/25 | 59.77 on 12/04/25 | 44.73 on 12/05/25 | ||
| 3-Month | |||||
| %Chg | +103.25% since 09/24/25 | -7.11% since 09/24/25 | -0.22% since 09/24/25 | ||
| Low | 36.85 on 09/26/25 | 48.02 on 11/21/25 | 10.50 on 11/04/25 | ||
| High | 80.99 on 12/19/25 | 78.48 on 10/08/25 | 51.33 on 10/03/25 | ||
| 6-Month | |||||
| %Chg | +79.31% since 06/24/25 | +21.23% since 06/24/25 | +48.84% since 06/24/25 | ||
| Low | 34.34 on 08/08/25 | 45.60 on 06/26/25 | 10.50 on 11/04/25 | ||
| High | 80.99 on 12/19/25 | 78.48 on 10/08/25 | 55.65 on 07/15/25 | ||
| Key Statistics | |||||
| Market Capitalization, $K | 5,281,136 | 5,380,638 | 4,980,068 | ||
| Shares Outstanding, K | 68,320 | 95,300 | 143,891 | ||
| Annual Sales | 0 | 37,310,000 | 8,185,146 | ||
| Annual Net Income | -182,150,000 | -366,250,000 | 2,372,842 | ||
| Last Quarter Sales | 0 | 890,000 | N/A | ||
| Last Quarter Net Income | -65,020,000 | -106,440,000 | N/A | ||
| 60-Month Beta | 1.41 | 1.74 | N/A | ||
| Per-Share Information | |||||
| Most Recent Earnings | -1.11 on 11/10/25 | -1.17 on 11/10/25 | N/A | ||
| Latest Earnings Date | 03/02/26 | 02/10/26 | 01/01/70 | ||
| Most Recent Dividend | N/A | N/A | N/A | ||
| Next Ex-Dividends Date | N/A | N/A | N/A | ||
| Ratios | |||||
| Price/Earnings ttm | 0.00 | 0.00 | 0.00 | ||